Terms: = Prostate cancer AND NKX2-1, BCH, 7080, ENSG00000136352, P43699, TITF1, TEBP, BHC, NKX2A, TTF-1, NKX2_1, NK-2
142 results:
1. ER-positive and BRCA2-mutated breast cancer: a literature review.
Li PC; Zhu YF; Cao WM; Li B
Eur J Med Res; 2024 Jan; 29(1):30. PubMed ID: 38184581
[TBL] [Abstract] [Full Text] [Related]
2. Towards estimating the carbon footprint of external beam radiotherapy.
Chuter R; Stanford-Edwards C; Cummings J; Taylor C; Lowe G; Holden E; Razak R; Glassborow E; Herbert S; Reggian G; Mee T; Lichter K; Aznar M
Phys Med; 2023 Aug; 112():102652. PubMed ID: 37552912
[TBL] [Abstract] [Full Text] [Related]
3. Disparities in prostate cancer Screening for Transgender Women: An Analysis of the MarketScan Database.
Premo H; Gordee A; Lee HJ; Scales CD; Moul JW; Peterson A
Urology; 2023 Jun; 176():237-242. PubMed ID: 36972765
[TBL] [Abstract] [Full Text] [Related]
4. Transcription factor nkx2-1 drives serine and glycine synthesis addiction in cancer.
Heylen E; Verstraete P; Van Aerschot L; Geeraerts SL; Venken T; Timcheva K; Nittner D; Verbeeck J; Royaert J; Gijbels M; Uyttebroeck A; Segers H; Lambrechts D; Cools J; De Keersmaecker K; Kampen KR
Br J Cancer; 2023 May; 128(10):1862-1878. PubMed ID: 36932191
[TBL] [Abstract] [Full Text] [Related]
5. Interobserver reproducibility of cribriform cancer in prostate needle biopsies and validation of International Society of Urological Pathology criteria.
Egevad L; Delahunt B; Iczkowski KA; van der Kwast T; van Leenders GJLH; Leite KRM; Pan CC; Samaratunga H; Tsuzuki T; Mulliqi N; Ji X; Olsson H; Valkonen M; Ruusuvuori P; Eklund M; Kartasalo K
Histopathology; 2023 May; 82(6):837-845. PubMed ID: 36645163
[TBL] [Abstract] [Full Text] [Related]
6. Increasing aggressive prostate cancer.
Shah N; Ioffe V; Chang JC
Can J Urol; 2022 Dec; 29(6):11384-11390. PubMed ID: 36495581
[TBL] [Abstract] [Full Text] [Related]
7. Hormone receptor binding, selectivity and cytotoxicity of steroid D-homo lactone loaded chitosan nanoparticles for the treatment of breast and prostate cancer cells.
Kuzminac IZ; Ćelić AS; Bekić SS; Kojić V; Savić MP; Ignjatović NL
Colloids Surf B Biointerfaces; 2022 Aug; 216():112597. PubMed ID: 35636320
[TBL] [Abstract] [Full Text] [Related]
8. Somatic-Type Yolk Sac Tumor Arising as a Predominant Component of Bladder Urothelial Carcinoma.
Collins K; Alkashash AM; Hwang M; Kaimakliotis HZ; Cheng L; Idrees MT
Int J Surg Pathol; 2022 Apr; 30(2):207-213. PubMed ID: 34255554
[TBL] [Abstract] [Full Text] [Related]
9.
Liu T; Liu C; Zhang Z; Zhang N; Guo X; Xia L; Jiang J; Xie Q; Yan K; Rowe SP; Zhu H; Yang Z
Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4508-4516. PubMed ID: 34170361
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases.
Bell PD; Huber AR; Agostini-Vulaj D
Diagn Pathol; 2021 Apr; 16(1):35. PubMed ID: 33892760
[TBL] [Abstract] [Full Text] [Related]
11. Using the Method of "Optical Biopsy" of Prostatic Tissue to Diagnose prostate cancer.
Artemyev DN; Kukushkin VI; Avraamova ST; Aleksandrov NS; Kirillov YA
Molecules; 2021 Mar; 26(7):. PubMed ID: 33807257
[TBL] [Abstract] [Full Text] [Related]
12. Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.
Baca SC; Takeda DY; Seo JH; Hwang J; Ku SY; Arafeh R; Arnoff T; Agarwal S; Bell C; O'Connor E; Qiu X; Alaiwi SA; Corona RI; Fonseca MAS; Giambartolomei C; Cejas P; Lim K; He M; Sheahan A; Nassar A; Berchuck JE; Brown L; Nguyen HM; Coleman IM; Kaipainen A; De Sarkar N; Nelson PS; Morrissey C; Korthauer K; Pomerantz MM; Ellis L; Pasaniuc B; Lawrenson K; Kelly K; Zoubeidi A; Hahn WC; Beltran H; Long HW; Brown M; Corey E; Freedman ML
Nat Commun; 2021 Mar; 12(1):1979. PubMed ID: 33785741
[TBL] [Abstract] [Full Text] [Related]
13. A comparative PET imaging study of
Ferguson S; Wuest M; Richter S; Bergman C; Dufour J; Krys D; Simone J; Jans HS; Riauka T; Wuest F
Nucl Med Biol; 2020; 90-91():74-83. PubMed ID: 33189947
[TBL] [Abstract] [Full Text] [Related]
14. The Association of Veterans' PSA Screening Rates With Changes in USPSTF Recommendations.
Becker DJ; Rude T; Walter D; Wang C; Loeb S; Li H; Ciprut S; Kelly M; Zeliadt SB; Fagerlin A; Lepor H; Sherman S; Ravenell JE; Makarov DV
J Natl Cancer Inst; 2021 May; 113(5):626-631. PubMed ID: 32797212
[TBL] [Abstract] [Full Text] [Related]
15. prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data.
Frendl DM; Epstein MM; Fouayzi H; Krajenta R; Rybicki BA; Sokoloff MH
Cancer Causes Control; 2020 Sep; 31(9):861-867. PubMed ID: 32556947
[TBL] [Abstract] [Full Text] [Related]
16. Development and validation of a nomogram including lymphocyte-to-monocyte ratio for initial prostate biopsy: a double-center retrospective study.
Zhou ZH; Liu F; Wang WJ; Liu X; Sun LJ; Zhu Y; Ye DW; Zhang GM
Asian J Androl; 2021; 23(1):41-46. PubMed ID: 32503957
[TBL] [Abstract] [Full Text] [Related]
17. The Incidence of Labelling of Non-Lung Adenocarcinomas With Antibodies Against ttf-1 and Diagnostic Implications.
Prabhakaran S; Woo WLW; Xing G; Moffat D; Hussey M; Henderson DW; Klebe S
Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):471-476. PubMed ID: 31135446
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of a decade of skin cancer prevention using a mobile unit in Brazil.
Silveira CEG; Mauad EC
Rural Remote Health; 2019 May; 19(2):4599. PubMed ID: 31084033
[TBL] [Abstract] [Full Text] [Related]
19. Baseline Basal Cell Hyperplasia Is not Associated With Baseline Lower Urinary Tract Symptoms, Baseline Clinical Prostatitis or prostate cancer in Repeat Biopsies.
Freitas D; Andriole GL; Freedland SJ; Neto BS; Moreira DM
Urology; 2019 Jul; 129():160-164. PubMed ID: 30914334
[TBL] [Abstract] [Full Text] [Related]
20. Preclinical Evaluation and Pilot Clinical Study of Al
Liu T; Liu C; Xu X; Liu F; Guo X; Li N; Wang X; Yang J; Yang X; Zhu H; Yang Z
J Nucl Med; 2019 Sep; 60(9):1284-1292. PubMed ID: 30796170
[TBL] [Abstract] [Full Text] [Related]
[Next]
